Wolfgang Hartwig
Supervisory Board member
Health care
CureVac
Germany
Biography
Wolfgang Hartwig is chairman of the Executive Board at LTS Lohmann Therapie-Systeme AG. Previously, he held various positions within Bayer Healthcare, including President and CEO of the Diagnostics Division and head of Global Pharmaceuticals Research and Development. He has served on public management and advisory boards including the Senatausschuss of the Helmholtz Association and the National Genome Research Initiative, and is at present a board member of several Biotech and Pharma companies in Europe. He has his own consulting firm and is Executive Consultant to the Bayer Holding Board. He is Honorary Professor at Westfaelische Wilhelms-University of Muenster. Hartwig is also member of CureVac’s Scientific Advisory Board.
Research Interest
Pharmaceuticals
